Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Egypt / NCT03770923
Recruiting Phase 3

Effect of Some Drugs on Rheumatoid Arithritis Activity

NCT03770923 · tracked via the Priya Life Science Egypt tracker
Sponsor
Sherief Abd-Elsalam
Phase
Phase 3
Started
2018-10-01
Last updated
2018-12-10

Condition(s) studied

Rheumatoid Arthritis

Investigational drug(s) / intervention(s)

Rupatadine →Montelukast →

Rupatadine: Rupatadine 10 mg daily

Montelukast: Montelukast 10 mg daily

Study summary

Effect of Some Drugs on Rheumatoid Arithritis Activity.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Rheumatoid arthritis Exclusion Criteria: * liver or renal disease

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sherief Abd-Elsalam Tanta Egypt Recruiting

On this site

📄 Singulair (montelukast) drug profile →

More Sherief Abd-Elsalam trials in Egypt

Citicoline as Neuroprotector in Neonates Exposed to Hypoxia Recruiting
Pantoprazole in Cisplatin Nephrotoxicity Recruiting
Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis Recruiting
Docosahexaenoic Acid on Breath Holding Spells in Children Recruiting
Effect of Some Drugs on Liver Fibrosis Recruiting

Other trials for the same condition

Novel Biomarkers in Assessment of Interstitial Lung Disease Associated With Rheumatoid Arthritis Patients Starting soon
Baricitinib Effects on Procoagulant State in Rheumatoid Arthritis Starting soon
Nerve Conduction Study for Assessment of Peripheral Neuropathy in Rheumatoid Arthritis Patients on the Janus Kinase Inhibitor Baricitinib Recruiting
Effect of Roflumilast and Desloratadine as Add-On Therapy in Patients With Rheumatoid Arthritis Recruiting
The Effect of Nicotinamide on the Clinical Outcome of Rheumatoid Arthritis Patients Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03770923 on ClinicalTrials.gov ↗ ← All trials in Egypt